Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LXRX

Lexicon Pharmaceuticals Inc

May 07 • 04:00PM ET

1.68

+0.08 5.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: XERS AUPH NUVB COGT SRRK

| Held by: VTI VXF SCHA VHT PRFZ SCHB QQQS BTEC TXS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.07	Insider Own	48.01%	Shs Outstand	423.68M	Perf Week	4.35%
Market Cap	711.78M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	1.02%	Shs Float	220.29M	Perf Month	0.60%
Enterprise Value	561.80M	PEG	-	EPS next Q	-0.05	Inst Own	21.41%	Short Float	10.75%	Perf Quarter	42.37%
Income	-26.09M	P/S	10.22	EPS this Y	-25.06%	Inst Trans	-28.81%	Short Ratio	10.56	Perf Half Y	26.32%
Sales	69.64M	P/B	5.68	EPS next Y	-17.68%	ROA	-9.21%	Short Interest	23.67M	Perf YTD	46.09%
Book/sh	0.30	P/C	3.56	EPS next 5Y	8.44%	ROE	-16.01%	52W High	1.95 -13.85%	Perf Year	145.26%
Cash/sh	0.47	P/FCF	-	EPS past 3/5Y	39.13% 23.47%	ROIC	-10.33%	52W Low	0.51 227.04%	Perf 3Y	-51.86%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	610.25% 15.72%	Gross Margin	99.49%	Volatility	6.10% 5.98%	Perf 5Y	-63.32%
Dividend TTM	-	EV/Sales	8.07	EPS Y/Y TTM	78.37%	Oper. Margin	-34.79%	ATR (14)	0.10	Perf 10Y	-86.25%
Dividend Ex-Date	-	Quick Ratio	4.87	Sales Y/Y TTM	123.12%	Profit Margin	-37.46%	RSI (14)	51.04	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	4.88	EPS Q/Q	96.28%	SMA20	-1.96%	Beta	0.97	Target Price	3.36
Payout	-	Debt/Eq	0.24	Sales Q/Q	1572.11%	SMA50	1.12%	Rel Volume	2.24	Prev Close	1.60
Employees	81	LT Debt/Eq	0.24	Earnings	May 07 BMO	SMA200	21.32%	Avg Volume	2.24M	Price	1.68
IPO	Apr 07, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	100.00% 115.55%	Trades		Volume	5,021,749	Change	5.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)